Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 84-2240648 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Cureshank has a singular purpose: To accelerate the development of treatments for Phelan-McDermid Syndrome and SHANK-related disorders. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.
Principal Officer
Abby Lievense
Total Revenue
$598K
FY2024
Total Expenses
$528K
FY2024
Net Assets
$1.1M
Program Ratio
86.5%
expenses on programs
Employees
0
Volunteers
7
Board Members
8
Voting
8
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.